Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 381 filings

Top spenders & firms Spend by issue

Clear
Q1
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy
View →
Q1
VENABLE LLP for MEDISCA INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New York · House · Senate · $20,000.00 income
Pharmacy
View →
Q1
THE HARPLE GROUP, LLC for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION (PILMA)
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $30,000.00 income
Pharmacy
View →
Q1
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $159,409.00 income
Health Issues, Pharmacy, Consumer Issues/Safety/Products, Taxation/Internal Revenue Code
View →
Q1
UC HEALTH for UC HEALTH
1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate
Medicare/Medicaid, Defense, Pharmacy
View →
Q1
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate
Pharmacy
View →
Q1
TAUZIN CONSULTANTS, LLC for RAZORMETRICS
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $40,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q1
SURESCRIPTS for SURESCRIPTS
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Health Issues, Pharmacy
View →
Q1
NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION for NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Family issues/Abortion/Adoption, Pharmacy
View →
Q1
THE ALS ASSOCIATION for THE ALS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Veterans
View →
RR
NATALIE FRAMSTED D/B/A NATALIE FRAMSTED for VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES
2nd Quarter (Apr 1 - June 30) 2026 · Ohio
Pharmacy
View →
RR
TYLER ROTUNDO D/B/A TYLER ROTUNDO for VENTURE GLOBAL ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES
2nd Quarter (Apr 1 - June 30) 2026 · Ohio
Pharmacy
View →
Q1
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER for CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy, Medicare/Medicaid
View →
Q1
PUBLIC CITIZEN for PUBLIC CITIZEN
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Banking, Civil Rights/Civil Liberties, Computer Industry, Consumer Issues/Safety/Products
View →
Q1
AMERICAN VETERINARY MEDICAL ASSOCIATION for AMERICAN VETERINARY MEDICAL ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Agriculture, Animals, Budget/Appropriations, Pharmacy
View →
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for GS1 US
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · $50,000.00 income
Health Issues, Food Industry (safety, labeling, etc.), Trade (domestic/foreign), Pharmacy
View →
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues, Medicare/Medicaid
View →
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Pharmacy, Defense, Taxation/Internal Revenue Code
View →
Q1
KOUNTOUPES DENHAM CARR & REID, LLC for AMERICAN KRATOM ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $50,000.00 income
Consumer Issues/Safety/Products, Health Issues, Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $50,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q1
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Previous Page 13 of 16 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem